Moleculin Biotech (MBRX) Other Gross PP&E Adjustments (2016 - 2025)
Moleculin Biotech (MBRX) has 10 years of Other Gross PP&E Adjustments data on record, last reported at -$343000.0 in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 23.78% year-over-year to -$343000.0; the TTM value through Sep 2025 reached -$343000.0, up 23.78%, while the annual FY2024 figure was -$2.5 million, 5.37% down from the prior year.
- Other Gross PP&E Adjustments reached -$343000.0 in Q3 2025 per MBRX's latest filing, up from -$370000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$81000.0 in Q1 2022 and bottomed at -$2.5 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$709000.0, with a median of -$425000.0 recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 57.88% in 2021, then plummeted 370.37% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.3 million in 2021, then plummeted by 60.84% to -$2.0 million in 2022, then fell by 18.2% to -$2.4 million in 2023, then fell by 5.37% to -$2.5 million in 2024, then skyrocketed by 86.45% to -$343000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$343000.0 in Q3 2025, -$370000.0 in Q2 2025, and -$398000.0 in Q1 2025.